Nasdaq |
US FDA panel backs approval for Indivior opioid addiction drug
Nasdaq Oct 31 (Reuters) - Indivior Plc's experimental drug to treat opioid addiction is effective and should be approved, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The panel voted 18-1 that the injectable drug, known as ... Indivior jumps 10% after FDA progress Indivior Drug to Fight Opioid Addiction Recommended by US Panel FDA Advisory Committees Recommend Approval of Indivior's RBP-6000 for the Treatment of Opioid Use Disorder |
from Health - Google News http://ift.tt/2gRQbmz
EmoticonEmoticon